Evidence map

TrialDiabetes care2014

Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.

Serge A Jabbour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

121 papers cite itlatest 60 shown

2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 24144654